Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Resverlogix Corp.    RVX   CA76128M1086

RESVERLOGIX CORP. (RVX)
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets

Resverlogix : IIROC Trade Resumption - Resverlogix Corp.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/13/2017 | 03:33pm CET

Toronto, Ontario--(Newsfile Corp. - October 13, 2017) - Trading resumes in:

Company:

Resverlogix Corp.

TSX Symbol:

RVX (all issues)

Resumption Time (ET):

10:00

 

 

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

- 30 -

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) - Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

© Newsfile Corp, source Press Releases

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RESVERLOGIX CORP.
02/12RESVERLOGIX : Highlights key accomplishments and 2018 targets
AQ
02/08Resverlogix Highlights Key Accomplishments and 2018 Targets
GL
01/11Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMAC..
GL
01/09RESVERLOGIX : and Medison Pharma Ltd. Announce Strategic Licensing Agreement
AQ
01/08RESVERLOGIX : and Medison Pharma Ltd. Announce Strategic Licensing Agreement
GL
01/08RESVERLOGIX AND MEDISON PHARMA LTD. : Alliance to focus on regulatory approval,..
AQ
01/08Resverlogix and Medison Pharma Ltd. Announce Strategic Licensing Agreement
GL
2017RESVERLOGIX : Streetwise Reports Examines How One Biotech Receives `Major Endors..
AQ
2017RESVERLOGIX : Announces filing of quarterly financial statements and management'..
AQ
2017RESVERLOGIX : Announces voting results from the 2017 annual meeting of sharehold..
AQ
More news
News from SeekingAlpha
02/13Resverlogix (RVXCF) Presents At BIO CEO & Investor Conference - Slideshow 
02/12FDA accepts Amicus' migalastat NDA for Fabry; action date August 13 
01/11Resverlogix to add U.S. sites to late-stage study of RVX-208 in T2D 
2017YOUR DAILY PHARMA SCOOP : Aclaris Gets Approval, Egalet Surges, Alnylam Gains As.. 
2017Resverlogix reports Q2 results 
Chart RESVERLOGIX CORP.
Duration : Period :
Resverlogix Corp. Technical Analysis Chart | RVX | CA76128M1086 | 4-Traders
Technical analysis trends RESVERLOGIX CORP.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Managers
NameTitle
Donald J. McCaffrey Chairman, President, CEO & Secretary
Anthony Brad Cann Chief Financial Officer
Norman C. W. Wong Chief Scientific Officer
Jan O. Johansson Senior Vice President-Medical Affairs
Michael T. Sweeney Senior Vice President-Clinical Development
Sector and Competitors
1st jan.Capitalization (M$)
RESVERLOGIX CORP.-25.12%214
CELLTRION, INC.--.--%34 853
IQVIA HOLDINGS INC2.41%20 749
LONZA GROUP-6.57%19 479
INCYTE CORPORATION-9.71%17 877
NEKTAR THERAPEUTICS39.74%13 613